Marx Biotechnology Overview
Marx Biotechnology (MBT) develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD) in order to save lives, reduce costs, and improve patient care, allowing doctors to make quick, accurate, and efficient decisions on how best to manage and treat their patients. MBT's blood test will diagnose the early onset of GVHD by monitoring functions on a molecular level that have to change for the disease to occur. The test provides results to physicians within two hours. MBT's big data platform uses a blood test to diagnose numerous diseases, monitor the patient's condition, and indicate what is causing the problem and the best way to treat it.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1.22M |
| Last funding | $50K |
| Stage | Seed |
| Rounds | 4 |
| Investors | 1 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | marxbio.com |
Locations
3 Ma'avar HaMitle, Jerusalem
Photos & Videos
1 item(s)
Marx Biotechnology Business
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesTarget Customer
Healthcare & Life SciencesHealthcareLaboratoriesProvidersCore Technology
—Tags (13)
medical-devicesdiagnosticsantibodieshospitalslaboratoriesdoctorsbiotechnologybiomarkersbig-datablood-testinflammatory-diseasesnon-invasivecancerMarx Biotechnology Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
Marx Biotechnology Lifecycle
Cumulative Funding Raised Over Time
All Events
Marx Biotechnology News
0 articlesNo news articles.
Marx Biotechnology Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
Marx Biotechnology Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | news, markets |
| BI Verification | RPA |
| Registrar ID | 514545912 |
| Crunchbase | marx-biotechnology |
| Last updater | Natasha Voloshin |
| Updater email | natashavolo@gmail.com |
| Last update | 2020-11-25T00:00:00.000Z |
| Created | 2014-07-06T00:00:00.000Z |
| Claimed | Yes |